Tuesday, December 30, 2025

The German Merck / Serono: Approx. 6 Million Babies Are The Result Of IVF, Life To Date...


First off -- the caveats: this is no relation to the US Merck (known as MSD in the EU -- including Italy). This is the German Merck KGaA.

Still, it is a fine win here, for bio-science -- and parents struggling to conceive, all over the globe (so long as they have around $50,000). Here's the story -- out of the South Korean papers, today:

. . .“Approximately 6 million babies have been born worldwide through in vitro fertilization (IVF) using the infertility treatment drugs [German Merck / Serono] developed. This accounts for 50% of all individuals born through artificial insemination since the introduction of IVF.”

Alexander Steinbach, Senior Vice President and head of the global infertility business unit at German biotech company Merck (Merck), is an expert who has worked in the infertility treatment sector for over 20 years. In a recent interview with this newspaper during his visit to Korea, he said, “It would not be an exaggeration to say that Merck’s infertility treatments have had a significant impact on global population policies.”

According to Steinbach, the roots of Merck’s infertility drug development trace back to Serono, a company established in Rome, Italy, 116 years ago. Serono moved its headquarters to Geneva, Switzerland, and laid the foundation for infertility treatment by introducing hormone therapy for the first time in the 1950s. The drug used when the world’s first test-tube baby was born in 1978 was also a Serono product. Merck acquired Serono in 2007. . . .


Now you know. Onward, grinning -- because as we've reported, Tangerine 2.0's 20-something year old minions in the West Wing cannot decide whether they are in favor of IVF (see RFK, Jr.'s new priority vouchers at FDA -- for it), or against it -- with the goofy MAGA Bible thumpers, who hold "only God decides whom may conceive and bear fruit". Damn. [Didn't God give us brains, and free will -- to invent. . . science-y things?]

नमस्ते

No comments: